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Background. Bacterial sepsis is amajor cause of illness in human immunodeficiency virus infected patients.There is scarce evidence
about sepsis among HIV patients in Ethiopia. This study aimed to determine the etiologic agents of bacterial sepsis and their
antibiotic susceptibility patterns among HIV infected patients. Methods. A cross-sectional study was carried out from March 1
to May 2, 2013. One hundred patients infected with HIV and suspected of having sepsis were included. Sociodemographic data
were collected by interview and blood sample was aseptically collected from study participants. All blood cultures were incubated
aerobically at 35∘C and inspected daily for 7 days.The positive blood cultures were identified following the standard procedures and
antimicrobial susceptibility testing was performed using disk diffusion technique. Data was entered by Epi-info version 3.5.1 and
analysis was done using SPSS version 20. Results. Of the study participants, 31 (31%) confirmed bacterial sepsis. The major isolates
were 13 (13%) Staphylococcus aureus, 8 (8%) coagulates negative staphylococci, and 3 (3%) viridans streptococci. Majority of the
isolates, 25 (80.6%), were multidrug resistant to two or more antimicrobial agents. Conclusions. Bacterial sepsis was a major cause
of admission for HIV infected patients predominated by Staphylococcus aureus and coagulase negative staphylococci species and
most of the isolates were multidrug resistant.
1. Introduction
Bacterial sepsis constitutes a significant public health prob-
lem and represents an important cause of morbidity and
mortality in HIV/AIDS patients in the world. Epidemiologic
studies have shown that 1% to 10% of the sepsis patients are
individuals with HIV/AIDS in ICU [1]. Sepsis is systemic
illness caused by microbial invasion of normally sterile parts
of the body and commonly defined as the presence of
infectionwith the systemic inflammatory response syndrome
(SIRS); it is the presence of two or more of the following
conditions: abnormal body temperature (<36∘C (96.8∘F) or
>38∘C (100.4∘F)); heart rate (>90 beats/min); respiratory
rate (>20 breaths/min); and white blood cell (WBC) count
(<4000/mm3 or >12,000/mm3) [2].
The source of infection can be lung, genitourinary tract,
gastrointestinal tract, skin or soft tissue, and so on [3].
Pathogenesis of bacteria due to the structural components of
the Gram negative and Gram positive bacteria is responsible
for initiating sepsis [4].
Sepsis can be caused by different types of bacteria. Gram
negative bacteria are the most commonly isolated in septic
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patients and have lipopolysaccharide or endotoxin structure
[5]. The percentage of patients with severe infections caused
by Gram positive bacteria has increased in recent years,
accounting for almost half of the incidents of septicemia
and severe systemic infections [6, 7]. Gram positive bacteria
have no endotoxin, but they cause sepsis indistinguishable
from Gram negative bacteria by two distinct mechanisms, by
releasing exotoxins that act as super antigens (e.g., staphy-
lococci or streptococci) and cell wall components of Gram
positive bacteria (both peptidoglycan and lipoteichoic acid)
[7].
The clinical syndrome is caused bymicroorganism and its
virulence factorswith the host and its inflammatory response.
Bacteria with special relevance for sepsis include Gram
positive: Streptococcus pneumonia, Streptococcus progenies,
Streptococcus agalactiae, and Staphylococcus auras; and Gram
negative: Neisseria meningitides, enteric (Escherichia coli,
Klebsiella, Proteus, Enterobacter, Serratia, Citrobacter, and
Salmonella), and nonenteric (Pseudomonas aeruginosa and
Acinetobacter) [5].
People living with HIV are at greater risk for sepsis
because of immune suppression. In areas of high HIV
prevalence, sepsis might contribute substantially to overall
mortality [8, 9].
Emerging of multidrug resistant bacteria can reduce
the management of bacterial infections. Bacterial infection
to the HIV infected cases can mostly be caused by the
multidrug resistant organism. Multidrug resistant organism
is a bacterium that is resistant to more than one antibiotic. If
bacteria are resistant to an antibiotic, certain drug treatments
will not work [10].
Like in many other developing countries, bacterial sepsis
and antibiotic resistant organism in Ethiopia are the most
common disease for mortality and morbidity. But there is
no evidence for bacterial sepsis among HIV/AIDS patients
and their interaction. Hence, this study aimed to analyze the
etiologic agents of bacterial sepsis and susceptibility pattern
of bacterial isolates among HIV infected patients.
2. Materials and Methods
2.1. Study Area. The study was conducted at University of
Gondar Teaching Hospital which is located in Gondar town,
Northwest Ethiopia, 737 km away from Addis Ababa. The
University Hospital was purposefully selected with the fact
that it is one of the biggest tertiary level referral and teaching
hospitals in the region visited by about six million people
from the surrounding zones and nearby regions both for
inpatient and for outpatient treatment. The hospital consists
of ART pharmacy, ART laboratory, ART clinic, ICU with 16
beds, 13 wards with 327 beds, and outpatient departments.
2.2. Study Design and Population. Hospital based cross-
sectional study was conducted among HIV/AIDS patients
attending at ART clinic fromMarch 1 to May 2, 2013.
2.3. Study Participants. All HIV/AIDS patients who were
suspected of having sepsis and attended the University of
Gondar Teaching Hospital during the study period were
enrolled in the study.
2.4. Inclusion Criteria. All confirmed HIV patients that were
suspected of having sepsis by clinicians were included in the
study.
2.5. Exclusion Criteria. Patients receiving antibiotic treat-
ment and neonates were excluded from the study.
2.6. Operational Definitions
(i) Sepsis suspect is a patient who fulfils definition of
SIRS.
(ii) SIRS is the presence of 2 or more of the following:
(a) Temperature <36∘C (96.8∘F) (hypothermia) or
>38∘C (100.4∘F).
(b) Heart rate >90 beats/min (tachycardia).
(c) Respiratory rate >20 breaths/min (tachypnea).
(d) WBC count <4000/mm3 (leucopenia) or
>12,000/mm3 (leukocytosis).
2.7. Sample Size and Sampling Technique. During the two-
month study period, 100 study subjects were enrolled using
convenient sampling technique from the study population
visiting University of Gondar Teaching Hospital.
2.8. Data Collection and Laboratory Methods. A pretested,
structured questionnaire was used to collect sociodemo-
graphic information, clinical signs, or symptoms by medical
doctor. The pretest of the questionnaire was conducted in
10 patients at University of Gondar Teaching Hospital and
pretest results were not included in the final results of the
research but we used it to validate the questionnaire before
conducting data collection.
2.8.1. Sample Collection and Handling. Blood samples were
collected from patients before antibiotic therapy by using
venipuncture technique. Careful skin cleaning using tincture
of iodine and 70% alcohol was done before drawing blood to
prevent contamination. Ten mL of blood sample from adults
and 2mL of blood sample from children were aseptically
collected following the request of the clinician. Then, it was
inoculated into a blood culture bottle each containing 45mL
of tryptone soy broth (TSB) (Oxoid) [11].
2.8.2. Culture and Identification. Blood cultures were incu-
bated aerobically at 35∘C and inspected daily for 7 days for
the presence of visible microbial growth by observing any
one of the following: turbidity, haemolysis, gas production,
and coagulation of broth. For blood cultures that showed
signs of microbial growth, subcultures were done onto blood,
chocolate, andMacConkey agar (Oxoid).Theblood andMac-
Conkey agar plates were incubated in aerobic and chocolate
agar inmicroaerophilic atmosphere using a candle jar at 35∘C
for 24–48 hours [11].
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Table 1: Sociodemographic characteristics of HIV/AIDS patients suspected of having sepsis admitted to University of Gondar Teaching
Hospital with their bacterial sepsis status, March 1, 2013, to May 2, 2013.
Characteristics Confirmed bacterial sepsis Total number (%) 𝜒2 𝑃 value
Yes number (%) No number (%)
Sex
Male 12 (30.8) 27 (69.2) 39 (39) 0.00 0.96
Female 19 (31.1) 42 (68.9) 61 (61)
Age (years)
<18 2 (33.3) 4 (66.7) 6 (6) 0.02 0.99
18+ 29 (30.9) 65 (69.1) 94 (94)
Residence
Urban 16 (36.4) 28 (63.6) 44 (44) 1.06 0.30
Rural 15 (26.8) 41 (73.2) 56 (56)
Educational status
Literate 17 (32.7) 35 (67.3) 52 (52) 0.15 0.70
Illiterate 14 (29.2) 34 (70.8) 48 (48)
Marital status
Single 8 (27.6) 21 (72.4) 29 (29)
1.28 0.73Married 18 (30.0) 42 (70.0) 60 (60)
Divorced 4 (44.4) 5 (55.6) 9 (9)
Widowed 1 (50.0) 1 (50.0) 2 (2)
Occupation
Farmer 5 (29.4) 12 (70.6) 17 (17)
2.49 0.96
House servant 4 (28.6) 10 (71.4) 14 (14)
House wife 5 (23.8) 16 (76.2) 21 (21)
Daily labor 5 (50.0) 5 (50.0) 10 (10)
Merchant 2 (28.6) 5 (71.4) 7 (7)
Employer (Gov’t) 5 (35.7) 9 (64.3) 14 (14)
Jobless 3 (30.3) 7 (70.0) 10 (10)
Driver 1 (25.0) 3 (75.0) 4 (4)
Others∗ 1 (33.3) 2 (66.7) 3 (3)
Total 31 (31) 69 (69) 100 (100)
∗: builder, waiter, and working as hair stylist, 𝜒2 = chi-squares.
All positive blood cultures were identified by their char-
acteristic appearance on their respective media and Gram
staining reaction and confirmed by the pattern of biochem-
ical reactions using the standard method. Gram negative
bacteria were identified by indole production, citrate uti-
lization, motility, urease, oxidase, gas production, hydrogen
sulfide production, carbohydrate fermentation, and lysine
decarboxylases production tests. For Gram positive bacteria:
for staphylococci, coagulase, catalase test, and manifold salt
agar were done and, for streptococci, bacitracin and opt chin
susceptibility tests were done. Blood culture broth which
shows no microbial growth within 7 days was reported as
culture negative, only after results were subcultured on blood,
MacConkey, and chocolate agar [11].
2.8.3. Antimicrobial Susceptibility Testing. Antimicrobial sus-
ceptibility testing was performed for all isolates according to
the criteria of the Clinical and Laboratory Standard Institute
(CLSI) by disk diffusion method [12].
From a pure culture 3–5 selected colonies of bacteria were
taken and transferred to a tube containing 5mL of tryptone
soy broth and mixed gently to a homogenous suspension
and incubated at 35∘C until the turbidity of the suspension
becomes adjusted to a McFarland 0.5. A; sterile cotton swab
was used and the excess suspension was removed by gentle
rotation of the swab against the surface of the tube. The swab
was then used to distribute the bacteria evenly over the entire
surface of Mueller-Hinton agar (Oxoid) and for fastidious
organisms’ sensitivity was done on blood and chocolate agar
plates [12].
The inoculated plates were left at room temperature to
dry for 3–5 minutes and a set of 14 antibiotic discs (Oxoid)
were placed 24mm apart from each other on the surface of a
Mueller-Hinton plate. Each disk was pressed down to ensure
complete contact with the agar surface. The drugs for disc
diffusion testing were in the following concentrations: ampi-
cillin (10 𝜇g), amoxicillin-clavulanic acid (30 𝜇g), ceftriaxone
(30 𝜇g), ciprofloxacin (5 𝜇g), chloramphenicol (30 𝜇g), sul-
famethoxazole/trimethoprim (25𝜇g), nitrofurantoin (50𝜇g),
erythromycin (15 𝜇g), gentamicin (10 𝜇g), methicillin (5𝜇g),
oxacillin (1 𝜇g), penicillin (10 IU), tetracycline (30 𝜇g), and
vancomycin (30𝜇g). Penicillin, vancomycin, erythromycin,
4 BioMed Research International
oxacillin, and methicillin were tested only for Gram positive
bacteria. The plates were then incubated at 35∘C for 24–48
hours. Diameters of the zone of inhibition around the disc
were measured to the nearest millimeter using the ruler, and
the isolates were classified as sensitive and resistant according
to the standardized table supplied by the CLSI [12].
2.8.4. Quality Control. Standard reference strains of Escher-
ichia coli (American Type Culture Collection- (ATCC-)
25922), Staphylococcus aureus (ATCC-25923), and Pseu-
domonas aeruginosa (ATCC-27853) were used as a quality
control throughout the study for culture and antimicrobial
susceptibility testing.
2.8.5. Data Analysis and Interpretation. Data entry was done
by Epi-info version 3.5.1 and analysis was done using statis-
tical package for social science (SPSS) software version 20.
Descriptive statistical methods were employed to describe
magnitude and percentage of sepsis. Chi-square and odds
ratio tests with 95% confidence interval were used to deter-
mine presence and strength of association. In all cases𝑃 value
less than 0.05 was considered as statistically significant.
2.8.6. Ethical Consideration. This study was approved by the
Research and Ethical Committee of the School of Biomedical
and Laboratory Sciences, College of Medicine and Health
Sciences, University of Gondar. Participation was voluntary
and informed written consent was obtained from each study
participant/guardian.The laboratory result was sent to physi-
cians for appropriate treatment of the study participants. All
information about the patients was kept confidential.
3. Results
One hundred HIV positive patients suspected of having
sepsis were included in this study. Out of this, 39 (39%) were
males and 61 (61%) were females. The age range of partici-
pants was 5–53 years with mean and SD 33.2 ± 9.8. There
was no significant association between the sociodemographic
characteristics of participants and bacterial sepsis (Table 1).
Thirty-one isolates were obtained from blood samples of
31 HIV infected patients suspected of having sepsis. Gram
positive isolates were predominantly recovered from the
blood cultures, that is, 26 (83.4%) (Table 2). S. aureus 13 (42%)
was the leading bacterial isolate followed by coagulase nega-
tive staphylococci species 8 (25.8%) in this study (Table 2).
Five different Gram negative bacteria, namely, E. coli, K.
ozaenae, H. influenzae, P. aeruginosa, and Serratia species,
were also isolated from HIV infected patients. P. aeruginosa
isolates were from a more extended (4 months) hospitalized
child found in critical condition in the pediatrics ward.
3.1. Susceptibility Pattern of the Isolates. The antibiotic resis-
tance patterns of the isolates to different antibiotics are
described in Table 3. Ciprofloxacin, gentamicin, chloram-
phenicol, and oxacillin were active against >75% of Gram
positive organisms. Amoxicillin-clavulanic acid, ceftriaxone,
nitrofurantoin, and vancomycin were active against 100% of
Table 2: Frequency of bacterial etiologies among HIV/AIDS
patients in the University of Gondar Teaching Hospital fromMarch
1, 2013, to May 2, 2013.
Etiologic agent Frequency Percent
Gram positive ((n = 26 (26%))
S. aureus 13 42
CONS 8 25.8
Viridans streptococci 3 9.7
S. pyogenes 2 6.5
Gram negative ((n = 5) (5%))
E. coli 1 3.2
K. ozaenae 1 3.2
H. influenzae 1 3.2
P. aeruginosa 1 3.2
Serratia species 1 3.2
Total 31 100
CONS: coagulase negative Staphylococcus.
Gram positive isolates. Ciprofloxacin and nitrofurantoin are
active against 100% of Gram negative isolates (Table 3).
The most common isolates, S. aureus and CONS, were
resistant mainly to ampicillin, methicillin, penicillin, and
tetracycline. Five S. aureus isolates were resistant to methi-
cillin while there was no vancomycin resistant S. aureus in
this study (Table 3).
All Gram negative isolates (5 in number) were resistant to
cotrimoxazole and most were resistant to ampicillin 4 (80%),
tetracycline 4 (80%), amoxicillin-clavulanic acid 4 (80%), and
chloramphenicol 2 (40%). The majority of Gram positive
isolates 17 (65.3%) were resistant to cotrimoxazole (Table 3).
All the five Gram negative isolates were also resistant
to cotrimoxazole. The isolated P. aeruginosa was resistant
to ampicillin, sulfamethoxazole, amoxicillin-clavulanic acid,
ceftriaxone, gentamicin, tetracycline, and chloramphenicol
except that of ciprofloxacin and nitrofurantoin (Table 3).
Majority of the isolates, 25 (80.6%), were multidrug
resistant, to two or more antimicrobial agents (Table 4). The
antibiogram of the two common bacterial isolates S. aureus
and CONS species was presented (Table 5).
4. Discussion
From this study, bacterial sepsis is one of the important
public health problems among HIV/AIDS patients (31%).
But this frequency was lower than previous reports from
China among surgically operated HIV/AIDS patients (41%)
[13] and Africa among HIV infected children (53%) [14]. The
magnitude difference might be due to the difference in the
study participants in which most (94%) were adults (Table 1).
In addition, lesser magnitude of bacterial sepsis among HIV
infected patients than surgically operated patients might also
be explained by the susceptibility of the latter group for local
bacterial infections that lead to bacterial sepsis.
In the present study, Gram positive sepsis (83.4%) was
more common than Gram negative sepsis (16.6%) (Table 2).
This may be due to the fact that the percentage of patients
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Table 4: Antibiotic resistance profile of bacterial isolate among HIV infected patients in the University of Gondar Teaching Hospital from
March 1, 2013, to May 2, 2013.
Bacterial isolate 𝑅
0
(%) 𝑅
1
(%) 𝑅
2
(%) 𝑅
3
(%) 𝑅
4
(%) 𝑅
5
and above (%)
Gram positive
S. aureus (𝑛 = 13) 1 (7.6) 1 (7.6) 5 (38.4) 2 (15.3) 1 (7.6) 3 (23.0)
CONS (𝑛 = 8) 0 (0) 1 (12.5) 3 (37.5) 1 (12.5) 0 (0) 3 (37.5)
Viridans streptococci(𝑛 = 3) 0 (0) 2 (66.6) 0 (0) 0 (0) 1 (33.3) 0 (0)
S. pyogenes (𝑛 = 2) 0 (0) 0 (0) 0 (0) 1 (50) 0 (0) 1 (50)
Total (26) 1 (3.8) 4 (15.4) 8 (30.8) 4 (15.4) 2 (7.7) 7 (26.9)
Gram negative
E. coli (𝑛 = 1) 0 (0) 0 (0) 0 (0) 0 (0) 1 (100) 0 (0)
K. ozaenae (𝑛 = 1) 0 (0) 0 (0) 0 (0) 0 (0) 1 (100) 0 (0)
H. influenzae (𝑛 = 1) 0 (0) 1 (100) 0 (0) 0 (0) 0 (0) 0 (0)
P. aeruginosa (𝑛 = 1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (100)
Serratia (𝑛 = 1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (100)
Total (n = 5) 0 (0) 1 (20) 0 (0) 0 (0) 2 (40) 2 (00)
Overall (n = 31) 1 (3.2) 5 (16.1) 8 (25.8) 4 (12.9) 4 (12.9) 9 (29.0)
𝑅
0
: nonresistant; 𝑅
1
: resistant for one antibiotic; 𝑅
2
: resistant for two antibiotics; 𝑅
3
: resistant for three antibiotics; 𝑅
4
: resistant for four antibiotics; 𝑅
5
and
above: resistant for five and greater than five antibiotics.
Table 5:Multidrug resistance profile of frequently isolate bacteria amongHIV infected patients in theUniversity ofGondar TeachingHospital
fromMarch 1, 2013, to May 2, 2013.
Bacterial species Antimicrobial agents Number of resistant isolates (%)
S. aureus
AMP and P 2 (15.3)
AMP and SXT 2 (15.3)
AMP and MET 1 (7.6)
AMP, MET, and OXA 1 (7.6)
AMP, SXT, and P 1 (7.6)
AMP, SXT, E, and TE 1 (7.6)
AMP, SXT, E, TE, and CAF 1 (7.6)
AMP, SXT, MET, TE, P, and OXA 1 (7.6)
AMP, P, E, TE, MET, and OXA 1 (7.6)
CONS
AMP and SXT 1 (12.5)
SXT and E 1 (12.5)
SXT and MET 1 (12.5)
SXT, MET, and E 1 (12.5)
SXT, MET, OXA, P, and TE 1 (12.5)
AMP, MET, CAF, CIP, E, P, SXT, and TE 1 (12.5)
AMP, MET, CAF, CN, E, OXA, P, SXT, and TE 1 (12.5)
AMP: ampicillin; SXT: sulfamethoxazole/trimethoprim; CIP: ciprofloxacin; E: erythromycin; CN: gentamicin; MET: methicillin; P: penicillin; TE: tetracycline;
CAF: chloramphenicol; OXA: oxacillin; CONS: coagulase negative staphylococci.
with severe infections caused by Gram positive bacteria has
increased in recent years, accounting for almost half of the
incidents of septicemia and severe systemic infections [6, 7].
Of the 13 S. aureus isolates, five (38.5%) were MRSA.
Methicillin resistant Staphylococcus aureuswere also reported
in different studies among HIV infected patients with the
prevalence of 43.5% MRSA bacteraemia [15] and 10.3% had
MRSA colonization [16]. These results showed that MRSA
are the common isolates among HIV infected patients.
The second most common isolates were CONS, 8 (25.8%).
A similar study also reported that CONS are the major cause
of bacterial infection in HIV/AIDS patients (58%) [17].
The antibiotic susceptibility test results revealed that
most isolates 22 (70.9%) were resistant for most antibiotics
tested. Gram positive and Gram negative isolates showed
65.3% and 100% resistance for cotrimoxazole, respectively
(Table 3). The reason for this high resistant isolates among
HIV/AIDS patients might be multifactorial. Inappropriate
use of the antibiotic by patients might be one possible reason
for the high resistance since cotrimoxazole has been given
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as prophylaxis for HIV/AIDS patients. This action might
also enhance the resistance to the antimicrobial agent. It is
also very difficult to generalize with this sample size about
the cotrimoxazole resistance among isolates of HIV/AIDS
patients. Large scale comparative study might answer the
question. From previous retrospective cohort study among
HIV infected patients, most of the isolates resist cotri-
moxazole widespread use for prophylaxis may exacerbate
antimicrobial resistance [14].
Gram positive bacteria also showed good sensitivity
patterns to amoxicillin-clavulanic acid, ceftriaxone, nitrofu-
rantoin, and vancomycin.
Gram negative bacteria showed good sensitivity pattern
only for ciprofloxacin and nitrofurantoin (Table 3). This
might be due to the use of this specific antibiotic which is not
widespread.
One P. aeruginosa isolate was from a more extended
(4 months) hospitalized child found in critical condition
in the pediatrics ward. P. aeruginosa have also been more
frequently recognized as nosocomial bacteraemia in HIV
infected patients [17].
5. Conclusions
The prevalence of culture that confirmed bacterial sepsis
amongHIV infected patients was high in this study (31%) and
the two most common causative agents for bacterial sepsis
are S. aureus and CONS. Amoxicillin-clavulanic acid, cef-
triaxone, nitrofurantoin, and vancomycin were 100% active
against Gram positive bacteria. Ciprofloxacin and nitrofu-
rantoin were 100% active against Gram negative bacteria.
Most of the isolates were multidrug resistant including
cotrimoxazole.
6. Recommendations
Based on the findings of this study, we recommend that
blood culture should be done for HIV infected patients
suspected of having sepsis. Amoxicillin-clavulanic acid, cef-
triaxone, nitrofurantoin, and vancomycin can be used against
Gram positives if the laboratory setups are incomplete.
Continuous antimicrobial susceptibility surveillance shall be
implemented in the study area with large scale study among
HIV/AIDS patients focusing on cotrimoxazole.
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